CSL346
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CSL346, covering 2023-12-06 to 2023-12-06. Get the full timeline:
Most recent: Clinical Trial Update: Vascular Endothelial Growth Factor-B (VEGF-B) Blockade With the Monoclonal Antibody CSL346 in Subjects With Diabetic Kidney Disease [Phase 2]